Pharma News
Looking out for latest news on Pharma Magazine?
Check out the latest Pharma news, Top news in Pharma Magazine, Leading Magazine in Pharma industry. Daily news updates pertinent to the industrial sectors we are engaged with are depicted on the news section of Pharma industry which we operate.
Innovent Announces the NMPA Granted New Indication Approval for BYVASDA® (Bevacizumab Biosimilar)
Monday, December 28, 2020Innovent Biologics Inc a worldclass biopharmaceutical company that develops manufactures and commercializes high quality medicines for the treatment of cancer metabolic autoimmune and other major diseases
A2 Biotherapeutics Enters Into Collaboration Agreement With Merck to Develop Allogeneic Cell Therapy for Solid Tumor Cancers
Thursday, December 24, 2020A Biotherapeutics wwwabiocom a biotechnology company developing innovative cell therapies for cancer patients with solid tumors today announced that it has entered into an agreement with Merck known as MSD outside the United States and Canada
UCSF and BridgeBio Pharma Collaborate to Accelerate the Development of Therapies for Genetic Diseases
Thursday, December 24, 2020UC San Francisco UCSF and BridgeBio Pharma Inc announced a partnership to drive the advancement of academic innovations in genetically driven diseases into potential therapeutics for patients
Skyhawk and Vertex Establish a Strategic Collaboration to Discover and Develop Novel Small Molecules that Modulate RNA Splicing for Serious Diseases
Wednesday, December 23, 2020Skyhawk Therapeutics Inc and Vertex Pharmaceuticals Incorporated announced a strategic research collaboration and licensing agreement aimed at the discovery and development of novel small molecules that modulate RNA splicing for the treatment of seri...
LSBio acquires Absolute Antibody Ltd.
Wednesday, December 23, 2020LSBio LSBio a leading provider of antibodies and reagents for life science research is pleased to announce the acquisition of Absolute Antibody Ltd based in Redcar United Kingdom and the subsidiary Kerafast The terms of the transaction were not disc...
Allecra Therapeutics and Shanghai Haini Pharmaceutical Announce Exclusive Licensing Agreement for Cefepime/enmetazobactam for Greater China
Tuesday, December 22, 2020Shanghai Haini Pharmaceutical Co Ltd Shanghai Haini the subsidiary of Yangtze River Pharmaceutical Group YRPG and Allecra Therapeutics Allecra announced that the companies have signed an exclusive licensing agreement under which Shanghai Haini will m...
Pierre Fabre Selects AGC Biologics as CDMO to manufacture the orphan drug ER-004
Tuesday, December 22, 2020AGC Biologics a leading global Biopharmaceutical Contract Development and Manufacturing Organization CDMO announced its partnership with Laboratoire Pierre Fabre to manufacture ER
Sosei Heptares and GSK Enter Global Collaboration and License Agreement Targeting Immune Disorders of the Digestive System
Monday, December 21, 2020Sosei Group Corporation announces it has entered into a global collaboration and license agreement with GlaxoSmithKline GSK The singletarget agreement is focused on the discovery and development of selective oral small molecule agonists of GPR
Antengene Announces its U.S. Partner, Karyopharm Therapeutics Inc., has received FDA Approval of XPOVIO® (Selinexor)
Monday, December 21, 2020Antengene Corporation Limited announced that the US Food and Drug Administration FDA has approved the supplemental New Drug Application sNDA submitted by its partner Karyopharm Therapeutics Inc
Ology Bioservices Enters Phase 1 Clinical Trial for Anti-COVID-19 Monoclonal Antibodies
Saturday, December 19, 2020Ology Bioservices Inc Ology Bio a biologics contract development and manufacturing organization CDMO announced today that it has begun dosing volunteers in a Phase clinical trial with ADM a cocktail of antiSARSCoV monoclonal antibodies